Fresenius MedCare: EPS up 8% in 2024
(CercleFinance.com) - Fresenius Medical Care reports 2024 EPS up 8% to E1.
83, and operating profit based on outlook up 18% to E1.81bn, thus reaching the top end of its target range.
At just over E19.3bn, sales of the German dialysis specialist fell by 1% on a reported basis, but rose by 4% on an organic basis. On an outlook basis, sales rose by 2%, in line with annual targets.
For 2025, the group anticipates operating profit growth in the upper 10% to upper 20% range, and in in the low single digit range for revenues, at constant exchange rates and excluding exceptional items.
Copyright (c) 2025 CercleFinance.com. All rights reserved.
83, and operating profit based on outlook up 18% to E1.81bn, thus reaching the top end of its target range.
At just over E19.3bn, sales of the German dialysis specialist fell by 1% on a reported basis, but rose by 4% on an organic basis. On an outlook basis, sales rose by 2%, in line with annual targets.
For 2025, the group anticipates operating profit growth in the upper 10% to upper 20% range, and in in the low single digit range for revenues, at constant exchange rates and excluding exceptional items.
Copyright (c) 2025 CercleFinance.com. All rights reserved.